Multicenter observational study of the efficacy and safety of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim analysis
Autor: | Konstantin Laktionov, Svetlana Protsenko, Anna Kornietskaya, Natalya Buevich, Fedor Moiseenko, E. Kushniruk, Sergey Orlov, Valeriy Breder, Daniil Stroyakovskiy, Danilova Ab, Tatyana Ionova, Alla L. Arzumanyan, Dilorom Latipova, Rashida Orlova, Tatyana Nikitina, E. Filippova, M. Kramchaninov, Larisa Bolotina, K. A. Sarantseva |
---|---|
Rok vydání: | 2017 |
Předmět: | |
Zdroj: | Web of Science |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |